Heart Disease News and Research

Latest Heart Disease News and Research

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.

5 Oct 2018

Tarragon and bitter melon supplements may be less helpful for women than men

Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist.

5 Oct 2018

New findings can promote healthy behavior among hypertensive women in Ghana

In the current issue of Family Medicine and Community Health (Volume 6,Number 3, 2018, pp.115-123, researchers Bishwajit Ghose and Sanni Yaya of the Faculty of Social Sciences, School of International Development and Global Studies University of Ottawa, Ottawa, ON, Canada, describe how this study is the first to assess the effect of socioeconomic status on blood pressure-controlling behavior among adult women with hypertension in Ghana.

5 Oct 2018

Multimodal fusion model can better predict cognitive impairment

A new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.

4 Oct 2018

New report provides overview of cancer risk among U.S. Hispanics/Latinos

The cancer burden in Puerto Rico, a U.S. territory with a 99% Hispanic population, is substantially different from that of Hispanics in the continental U.S., according to Cancer Statistics for Hispanics/Latinos, 2018.

4 Oct 2018

Gut microbiome appears to play key role in heart transplant outcomes

In a new study, researchers at the University of Maryland School of Medicine have found that the gut microbiome appears to play a key role in how well the body accepts a transplanted heart. The scientists found a causal relationship between the presence of certain microbes and transplant outcome.

4 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

Yo-yo dieting increases risk of heart attack and stroke, finds study

In the study, sudden changes in metabolic health parameters were associated with a raised risk of heart attacks, strokes and even early deaths.

4 Oct 2018

Study suggests diet as major contributor for high risk of hypertension in black Americans

New findings suggest that diet is a major contributor for the increased risk of hypertension in black compared to white Americans.

4 Oct 2018

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study showed treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in people at high risk of serious complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

4 Oct 2018

High-quality hospitals provide lower cost care for 82% of diagnoses, analysis reveals

High-quality hospitals deliver lower-cost care for 82% of diagnoses, according to a new analysis that Advisory Board released today on variations in care that do not improve care costs or patient outcomes.

3 Oct 2018

Previously unknown genetic causes of mitochondrial diseases identified

An international team of scientists led by researchers from the University of Colorado School of Medicine have identified previously unknown genetic causes of mitochondrial diseases.

3 Oct 2018

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Even lightest daily drinkers have increased mortality risk

Drinking a daily glass of wine for health reasons may not be so healthy after all, suggests a new study from Washington University School of Medicine in St. Louis.

3 Oct 2018

InterSystems launches world's first and only data platform engineered for healthcare applications

InterSystems, a global leader in information technology platforms for health, business, and government applications, today announced the launch of InterSystems IRIS for Health, designed to deliver fast and sustainable value to organizations developing data-intensive healthcare applications.

3 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Heart Disease News and Research

Latest Heart Disease News and Research

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Tarragon and bitter melon supplements may be less helpful for women than men

New findings can promote healthy behavior among hypertensive women in Ghana

Multimodal fusion model can better predict cognitive impairment

New report provides overview of cancer risk among U.S. Hispanics/Latinos

Gut microbiome appears to play key role in heart transplant outcomes

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Yo-yo dieting increases risk of heart attack and stroke, finds study

Study suggests diet as major contributor for high risk of hypertension in black Americans

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

High-quality hospitals provide lower cost care for 82% of diagnoses, analysis reveals

Previously unknown genetic causes of mitochondrial diseases identified

Newly discovered compounds may explain whole grain health benefits

Even lightest daily drinkers have increased mortality risk

InterSystems launches world's first and only data platform engineered for healthcare applications

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New project aims to create complete cellular blueprint of zebrafish development

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

World Stomach Day: International initiative to raise awareness and support for a vital organ

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Heart Disease News and Research

Latest Heart Disease News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in